Release Date: 28/04/23 08:05 Summary: Change of substantial holding from RMS Price Sensitive: No Download Document 96.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%